How to Buy Kiora Pharmaceuticals Stock
Kiora Pharmaceuticals Inc
Kiora Pharmaceuticals, Inc. , a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States.
Kiora Pharmaceuticals stock last closed at $2.87, up 2.87% from the previous day, and has decreased 34.25% in one year. It has overperformed other stocks in the Biotechnology industry by 0.43 percentage points. Kiora Pharmaceuticals stock is currently +14.34% from its 52-week low of $2.51, and -50.17% from its 52-week high of $5.76.
At the moment, there are 3M KPRX shares outstanding. The market value of KPRX is $8.61M. In the past 24 hours, 4166 KPRX shares were traded.
How to Buy Kiora Pharmaceuticals Stock
Not sure how to invest in Kiora Pharmaceuticals stock? Here's how.
- Choose where to buy Kiora Pharmaceuticals stock: You need to decide on an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you decide where to buy Kiora Pharmaceuticals stock.
- Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Put funds into your brokerage account: Choose your payment method and add your details.
- Analyze Kiora Pharmaceuticals stock: The Kiora Pharmaceuticals ticker symbol is KPRX. Is Kiora Pharmaceuticals stock a good investment? Should you buy shares of KPRX? How do KPRX's underlying business fundamentals look? Do top analysts think Kiora Pharmaceuticals is a good buy? Why has KPRX's stock price moved recently? (Hint: Our stock market research website can help you decide if KPRX is a good stock to buy).
- Place your KPRX buy order: Decide if you will purchase KPRX shares at the current market price or use a limit order to purchase KPRX stock at a specific price.
- Get notifications regarding your investment in KPRX: Create a watchlist to watch your position in Kiora Pharmaceuticals shares.
Step 1: Choose where to buy Kiora Pharmaceuticals stock
You will need an online brokerage account in order to access the NASDAQ market and buy KPRX stock.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global markets: From Tech to Healthcare, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've picked the right brokerage, the next step is to fill out some personal details so you are able to buy KPRX today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to create a new brokerage account.
- Send your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you've created your account on the best investment app, you can securely and quickly fund your account:
Watch the video below for more details depositing money into your new brokerage account.
Step 4: Analyze Kiora Pharmaceuticals stock
After you have chosen the best place to buy Kiora Pharmaceuticals stock, it's critical to evaluate their stock prior to buying, so you can comprehend the risk and opportunity.
Kiora Pharmaceuticals stock at a glance
Kiora Pharmaceuticals Due Diligence Checks
WallStreetZen was created to help everyday investors do more in-depth fundamental analysis.
You can see all of the due diligence checks on KPRX's stock page.
Is KPRX stock overvalued?
You can use many financial metrics, analyses, models, and charts to gauge KPRX's true value.
Using relative valuations methods:
- KPRX may be undervalued based on its P/E ratio of 3.09x, relative to Biotechnology industry P/E ratio of -184.27x
- KPRX could be undervalued based on its P/B ratio of 0.33x, relative to Biotechnology industry P/B ratio of 4.04x
You can access more valuation research on KPRX's stock here.
KPRX Financial Summary
Positive Financial Indicators:
- There are more short-term assets than long-term liabilities on the KPRX balance sheet.
- There are more short-term assets than short-term liabilities on the KPRX balance sheet.
- KPRX's operating cash flow of $8.56M allows it to safely service it's debt of $57.17k.
- Total KPRX debt is lower than 5 years ago, relative to shareholder equity.
- KPRX earnings of $5.68M is not enough to cover its interest payments.
Negative Financial Indicators:
- KPRX has a relatively high debt to equity ratio of 0.42.
Is KPRX stock a Buy, Hold, or Sell, according to analysts?
Out of 1 Wall Street analysts who give recommendations on KPRX, the consensus analyst rating on KPRX is a Buy
It's important to note that analyst forecasts are not recommendations, nor are they financial advice.
You can dive deeper into what analysts are forecasting on the Kiora Pharmaceuticals stock forecast page.
KPRX Momentum
KPRX Revenue
Last year, KPRX revenue was $16.02M. Over the past five year, KPRX's revenue has gone up by 42.93% per year. This was slower than the Biotechnology industry average of 44.31%.
You can research KPRX's earnings and revenue performance here.
What are KPRX executives and large shareholders up to?
In the past year, insiders at KPRX have bought more shares than they have sold.
Carmine N. Stengone, Director of KPRX, was the latest KPRX insider to buy. They bought $4,600.00 worth of KPRX shares on Sep 11, 2024.
Dig into more about who owns KPRX shares here.
Can I get consistent income from KPRX stock?
No, Kiora Pharmaceuticals doesn't provide an income stream by paying out dividends.
What others are saying about KPRX
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Place your KPRX buy order
There are two main types of orders:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are generally sufficient. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at an exact dollar amount, use a limit order.
Press the Open Trade button and eToro will place the order.
If you want additional help with investing in stocks on eToro, click the how to video below:
Step 6: Get notifications regarding your investment in KPRX
Now that you own some KPRX shares, you'll want to stay up-to-date on your investment.
Make a watchlist to get alerted to the latest events about your KPRX stock.
KPRX Feed
How to Buy Stock in Kiora Pharmaceuticals
To reiterate, here are the 6 steps for buying Kiora Pharmaceuticals stock:
- Choose where to buy Kiora Pharmaceuticals stock
- Create a brokerage account
- Put funds into your brokerage account
- Analyze Kiora Pharmaceuticals stock
- Place your KPRX buy order
- Get notifications regarding your investment in KPRX
If you are looking for a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to get updates on your investment in Kiora Pharmaceuticals, click below.
Other "How To" Guides You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.